COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,745 Articles (22,502 medRxiv, 8,243 bioRxiv)

Most recent first Previous |  Page 850: Articles 8491-8500  | Next

Sleep and circadian rhythm disruption alters the lung transcriptome to predispose to viral infection
Taylor, L., von Lendenfeld, F., Ashton, A., Sanghani, H., Tam, E., Usselmann, L., Verennetikova, M., Dallmann, R., McKeating, J., Vasudevan, S., Jagannath, A.
10.1101/2022.02.28.482377 — Posted: 2022-03-01
Mutation patterns in SARS-COV-2 Alpha and Beta variants indicate non-neutral evolution
Kurpas, M. K., Kimmel, M.
10.1101/2022.02.28.482283 — Posted: 2022-03-01
Use of Convalescent Plasma Therapy with Best Available Treatment (BAT) among Hospitalized COVID-19 Patients: A Multi-Center Study
Mesina, F. Z., Comia, M. V. M., Ongkingco, J. M. P., Lafavilla, J. R., Julian, J. C., Relos, J. A., Torres, R. P.
10.1101/2022.02.23.22271424 — Posted: 2022-03-01
COVID-19 testing: disparity between national and institution-based case detection
Aitman, T. J., Bauld, L., Carruthers, K. F., Gilbert, N., Turok, N.
10.1101/2022.02.21.22270847 — Posted: 2022-03-01
Vaccine hesitancy strongly correlates with COVID-19 deaths underreporting
Sobieszek, A., Lipniacka, M., Lipniacki, T.
10.1101/2022.02.27.22271579 — Posted: 2022-03-01
Effect of booster vaccination against Delta and Omicron variants in Iceland
Norddahl, G. L., Melsted, P., Gunnarsdottir, K., Halldorsson, G. H., Olafsdottir, T. A., Gylfason, A., Kristjansson, M., Magnusson, O. T., Sulem, P., Gudbjartsson, D. F., Thorsteinsdottir, U., Jonsdottir, I., Stefansson, K.
10.1101/2022.02.26.22271509 — Posted: 2022-03-01
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
Karger, A. B., Brien, J. D., Christen, J. M., Dhakal, S., Kemp, T. J., Klein, S. L., Pinto, L. A., PREMKUMAR, L., Roback, J. D., Binder, R. A., Boehme, K. W., Boppana, S., Crawford, J. M., Daiss, J. L., Dupuis, A. P., Espino, A. M., Forconi, C., Forrest, J. C., Girardin, R. C., Haddad, N. S., Heaney, C. D., Hunt, D. T., Kennedy, J. L., King, C. L., Kruczynski, K., LaBaer, J., Lee, F. E.-H., Lee, W. T., Liu, S.-L., Lozanski, G., Moormann, A. M., Murugan, V., Okoye, N. C., Pantoja, P., Payne, A. F., Park, J., Pinninti, S., Pinto, A. K., Pisanic, N., Qiu, J., Sariol, C. A., Song, L., Steffen, T. L., Stone, E. T., Styer, L. M., Suthar, M. S., Thomas, S. N., Thyagarajan, B., Yates, J. L., Sobhani, K.
10.1101/2022.02.27.22271399 — Posted: 2022-03-01
An Immunobridging study to evaluate the neutralizing antibody titer in adults immunized with two doses of either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901.
Estrada, J. A. G., Cheng, C.-Y., Ku, S.-Y., Hu, H.-C., Yeh, H.-W., Lin, Y.-C., Chen, C.-P., Cheng, S.-H., Lin, I.-F.
10.1101/2022.02.26.22271364 — Posted: 2022-03-01
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): a randomized, observer-blinded, placebo-controlled trial
Jin, P., Guo, X., Chen, W., Ma, S., Pan, H., Dai, L., Du, P., Wang, L., Jin, L., Chen, Y., Shi, F., Liu, J., Xu, X., Zhang, Y., Gao, G. F., Chen, C., Feng, J., Li, J., Zhu, F.-C.
10.1101/2022.02.24.22271445 — Posted: 2022-03-01
Medium-term impacts of the waves of the COVID-19 epidemic on treatments for non-COVID-19 patients in intensive care units: a retrospective cohort study in Japan
Watanabe, S., Shin, J.-h., Okuno, T., Morishita, T., Takada, D., Kunisawa, S., Imanaka, Y.
10.1101/2022.02.28.22271604 — Posted: 2022-02-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).